Groups

BMS354825

1–15 of 15

0 selected

rhens...@aol.com

11/23/11

Re:You can read about useful properties of these drugs here:

Lose some pounds with me!. http://adminacu.com.br/pgphp?rhotmailID=86iw4

unread,

Re:You can read about useful properties of these drugs here:

Lose some pounds with me!. http://adminacu.com.br/pgphp?rhotmailID=86iw4

11/23/11

11/15/11

Re: [BMS354825] Digest for bms354825@googlegroups.com - 1 Message in 1 Topic

-Nancy Wilhelm --- bms3...@googlegroups.com wrote: From: bms3...@googlegroups.com To: Digest

unread,

Re: [BMS354825] Digest for bms354825@googlegroups.com - 1 Message in 1 Topic

-Nancy Wilhelm --- bms3...@googlegroups.com wrote: From: bms3...@googlegroups.com To: Digest

11/15/11

rhens...@aol.com

11/15/11

Make the right choice.... http://211.20.97.26/pgphp?ljfriend=24zo5

unread,

Make the right choice.... http://211.20.97.26/pgphp?ljfriend=24zo5

11/15/11

rhens...@aol.com

11/13/11

Re:I won�t find the place better than this in the world!

You will squeal with delight�after visiting this site!.. http://www.biz-analyst.com/m.friends.page.

unread,

Re:I won�t find the place better than this in the world!

You will squeal with delight�after visiting this site!.. http://www.biz-analyst.com/m.friends.page.

11/13/11

rhens...@aol.com

7/26/11

http://www.papamimi.com/wp-includes/sha26.htm

unread,

http://www.papamimi.com/wp-includes/sha26.htm

7/26/11

holly...@yahoo.com

3/7/06

Hi all. I just joined the group today looking for any advice. After 5.5 years on Gleevec my disease

unread,

Hi all. I just joined the group today looking for any advice. After 5.5 years on Gleevec my disease

3/7/06

3/1/06

BMS - Ive got it

Thankyou to all for your words of encouragement and prayers for me to get another drug other than

unread,

BMS - Ive got it

Thankyou to all for your words of encouragement and prayers for me to get another drug other than

3/1/06

2/2/06

Atom & RSS Feeds

Atom 1.0 15 New messages 50 New messages 15 New topics 50 New topics RSS 2.0 15 New messages 50 New

unread,

Atom & RSS Feeds

Atom 1.0 15 New messages 50 New messages 15 New topics 50 New topics RSS 2.0 15 New messages 50 New

2/2/06

9/11/05

[BMS354825] New Articles Posted On CML Newswire

I have posted over 30 new articles today at http://cmlsupport.blogspot.com on various news CML

unread,

[BMS354825] New Articles Posted On CML Newswire

I have posted over 30 new articles today at http://cmlsupport.blogspot.com on various news CML

9/11/05

7/30/05

[BMS354825] New Clinical Trials Now Recruiting For VX-680 For T315I Mutation

Clinical trials are now recruiting patients for the new Merck drug VX-680 which has been developed to

unread,

[BMS354825] New Clinical Trials Now Recruiting For VX-680 For T315I Mutation

Clinical trials are now recruiting patients for the new Merck drug VX-680 which has been developed to

7/30/05

7/30/05

[BMS354825] New Novartis CML Clinical Trials

2) Novartis Oncology is studying an investigational drug in patients with different types of Leukemia

unread,

[BMS354825] New Novartis CML Clinical Trials

2) Novartis Oncology is studying an investigational drug in patients with different types of Leukemia

7/30/05

7/27/05

[BMS354825] New Drug For T315I Mutation Which Causes Gleevec Resistance

New Drug For T315I Mutation Which Causes Gleevec Resistance Ambit Biosciences has announced the

unread,

[BMS354825] New Drug For T315I Mutation Which Causes Gleevec Resistance

New Drug For T315I Mutation Which Causes Gleevec Resistance Ambit Biosciences has announced the

7/27/05

6/22/05

[AMN107] Diagnosis

----- Original Message ----- From: Ruth McIntosh To: AMN...@cmlhope.com Sent: Wednesday, June 22,

unread,

[AMN107] Diagnosis

----- Original Message ----- From: Ruth McIntosh To: AMN...@cmlhope.com Sent: Wednesday, June 22,

6/22/05

6/22/05

[BMS354825] Correlation of Clinical Response to BMS-354825 with BCR-ABL Mutation Status in Imatinib-Resistant Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Associated Acute Lymphoblastic Leukemia (Ph+ ALL).

Background: Relapse of CML on imatinib is most often associated with point mutations in the BCR-ABL

unread,

[BMS354825] Correlation of Clinical Response to BMS-354825 with BCR-ABL Mutation Status in Imatinib-Resistant Patients with Chronic Myeloid Leukemia (CML) and Philadelphia Chromosome-Associated Acute Lymphoblastic Leukemia (Ph+ ALL).

Background: Relapse of CML on imatinib is most often associated with point mutations in the BCR-ABL

6/22/05

6/21/05

[BMS354825] First Message For Archives

unread,

[BMS354825] First Message For Archives

6/21/05

Search

Clear search

Close search

Google apps

Main menu